p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Narra J
Niken A. Utami
Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Obstetrics and Gynecology, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Comparative study of quality of life between endometriosis patients receiving GnRH agonist and dienogest therapy: A cross-sectional study using Endometriosis Health Profile-30 (EHP-30) Iqbal A. Pravasta; Rajuddin Rajuddin; Cut M. Yeni; Dewi K. Rusly; Niken A. Utami
Narra J Vol. 6 No. 2 (2026): August 2026
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v6i2.3097

Abstract

Endometriosis is a chronic gynecological disease that substantially impairs quality of life. Gonadotropin-releasing hormone (GnRH) agonists and dienogest are commonly used hormonal therapies for endometriosis; however, direct comparisons of their effects on quality of life remain limited. This study aimed to compare quality of life between patients with endometriosis receiving GnRH agonist and dienogest therapy using the Endometriosis Health Profile-30 (EHP-30). A comparative cross-sectional study was conducted among 100 patients with endometriosis at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia, comprising 50 patients receiving GnRH agonist therapy and 50 receiving dienogest therapy. Quality of life was assessed using the Indonesian version of the EHP-30, with higher scores indicating poorer quality of life. Between-group comparisons and multiple linear regression were performed. Patients receiving dienogest had significantly lower total EHP-30 scores than those receiving GnRH agonist therapy (20.1±9.6 vs 43.7±14.9; p<0.001). Significantly lower scores were also observed in all EHP-30 core domains and optional modules in the dienogest group (all p<0.001), with the largest differences observed in pain, control and powerlessness, and emotional well-being. In multivariable analysis, dienogest therapy remained independently associated with a lower total EHP-30 score after adjustment for demographic and clinical factors (β=−23.625; 95%CI: −28.803 to −18.447; p<0.001). This study highlights that dienogest therapy was associated with better quality of life than GnRH agonist therapy among patients with endometriosis. These findings support the consideration of dienogest as a patient-centered hormonal option when quality of life is a major treatment priority.
Cortisol and pregnancy-related anxiety in relation to preeclampsia among third-trimester pregnant women: A case–control study from Aceh, Indonesia Teuku M. Hezron; Tgk. Puspa Dewi; Yusra Septivera; Rajuddin Rajuddin; Niken A. Utami
Narra J Vol. 5 No. 3 (2025): December 2025
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v5i3.2985

Abstract

Despite extensive research, the interplay between hormonal stress markers and pregnancy-specific anxiety in the pathogenesis of preeclampsia remains insufficiently understood. This study aimed to analyze the simultaneous relationships between serum cortisol levels, pregnancy-related anxiety, and the occurrence of preeclampsia among third-trimester pregnant women. A case–control study was conducted at three hospitals in Banda Aceh, Indonesia, involving third-trimester pregnant women. Serum cortisol concentrations were measured using an immunoassay, and anxiety levels were assessed with the validated Pregnancy Related Anxiety Questionnaire (PRAQ). Preeclampsia diagnosis followed standard clinical and laboratory criteria. Associations between cortisol levels (categorized into high and normal) and PRAQ scores (classified as high and low–moderate) with preeclampsia were evaluated using the Chi-squared test, and crude odds ratios (OR) with 95% confidence intervals (95%CI). The Spearman’s correlation was used to determine the correlation between cortisol levels and PRAG scores. A total of 66 pregnant women were included in the final analysis (33 with preeclampsia and 33 with normal pregnancy). Women with high serum cortisol levels had a markedly greater likelihood of developing preeclampsia compared with those with normal cortisol levels (odds ratio (OR)=34.00; 95% confidence interval (95%CI): 4.93–234.46). Similarly, women with high pregnancy-related anxiety exhibited a significantly elevated risk of preeclampsia (OR=16.71; 95%CI: 4.95–56.39). No significant correlation was observed between cortisol levels and PRAQ scores in both groups (preeclampsia: r=-0.041, p=0.821; normal pregnancy: r=0.278, p=0.117). In conclusion, elevated serum cortisol and high pregnancy-related anxiety are independently associated with preeclampsia, although not directly correlated with each other. These findings highlight the potential of dual screening for cortisol and pregnancy-specific anxiety as an innovative approach for early identification of women at high risk of preeclampsia.